SYNCROSOME - Cardiovascular Preclinical expert
Created in 2000
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
15 1,303Activities
Technologies
Entity types
Location
163 Av. de Luminy, 13009 Marseille, France
Marseille
France
Employees
Scale: 11-50
Estimated: 9
SIREN
433592854Engaged corporates
2
2 1Added in Motherbase
5 years, 2 months ago
biotech Value proposition
Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services.
At a glimpse
SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years.
Range of services
SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available.
Our added value
We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim to provide our clients with the most relevant data using state-of-the-art techniques and imaging, still to offer better predictability of compounds' efficacy.
Tailored services
Beyond expertise, our flexible and human-sized organization can design and operate tailored drug efficacy studies to fit client's needs.
Check out our cardiovascular models, tailored to your HF & cardiac disease challenges in our website !
In Depth Efficacy Characterization CRO, In Vivo Drug Efficacy Studies, Blood Brain Barrier Passage / CNS-PK, Early bioavailibity Studies (PK/PD), animal model, Cardiovascular preclinical CRO, CNS preclinical CRO, Respiratory preclinical CRO, Pulmonary Arterial hypertension PAH, Myocardial ischemia, heart failure, HFrEF, HFpEF, and acute myocardial ischaemiaOriginal language
Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services.
At a glimpse
SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years.
Range of services
SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available.
Our added value
We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim to provide our clients with the most relevant data using state-of-the-art techniques and imaging, still to offer better predictability of compounds' efficacy.
Tailored services
Beyond expertise, our flexible and human-sized organization can design and operate tailored drug efficacy studies to fit client's needs.
Check out our cardiovascular models, tailored to your HF & cardiac disease challenges in our website !
Preclinical CRO Services, In Vivo Disease Models | Syncrosome
Syncrosome has developed and validated more than 15 disease models in CNS, Cardiovascular, Gastro enterology, Respiratory and Metabolic Disorders.
https://www.syncrosome.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 3 Jun 2019 19 May 2024 | | |
 Grand Luminy Technopole Business Consulting and Services | Grand Luminy Technopole Business Consulting and Services | Not capitalistic Not partnership Event 24 Dec 2020 21 Jun 2024 | | |